Log In
Print
BCIQ
Print
Print this Print this
 

CALY-002

  Manage Alerts
Collapse Summary General Information
Company iDD Biotech S.A.S.
DescriptionHumanized mAb against undisclosed target
Molecular Target Undisclosed
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationCeliac disease
Indication DetailsTreat Type II refractory Celiac disease
Regulatory Designation

Partner

Calypso Biotech S.A.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today